Bubs cuts US staff as it readies for FDA visit
The US Food and Drug Administration will audit Bubs Australia’s Deloraine, canning facility in Victoria next week as the infant formula company further axes jobs at its US office.
Former Bubs CEO Kristy Carr and executive chairman Dennis Lin are also suing Bubs and the non-executive directors of the baby formula group – Katrina Rathie, Steven Lin, Reg Weine and Paul Jensen – in the Victorian Federal Court over their removal from the company co-founded by Ms Carr.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Manufacturing
Fetching latest articles